About LCA-Vision (NASDAQ:LCAV)
LCA-Vision Inc. is a provider of fixed-site laser vision correction services at its LasikPlus vision centers. The Company's vision centers provide the staff, facilities, equipment and support services for performing laser vision correction that employ advanced laser technologies to help correct nearsightedness, farsightedness and astigmatism. The Company's vision centers are supported by independent, ophthalmologists and credentialed optometrists, as well as other healthcare professionals. The ophthalmologists perform the laser vision correction procedures in the Company's vision centers, and ophthalmologists or optometrists conduct pre-procedure evaluations and post-operative follow-up care in-center. Most of the Company's patients receive a procedure called laser-assisted in situ keratomileusis (LASIK). As of December 31, 2011, it had performed over 1.2 million laser vision correction procedures in its vision centers in the United States and Canada.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
LCA-Vision (NASDAQ:LCAV) Frequently Asked Questions
What is LCA-Vision's stock symbol?
LCA-Vision trades on the NASDAQ under the ticker symbol "LCAV."
How were LCA-Vision's earnings last quarter?
LCA-Vision Inc. (NASDAQ:LCAV) issued its quarterly earnings data on Wednesday, April, 30th. The healthcare company reported ($0.01) earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.24. The healthcare company had revenue of $25.53 million for the quarter, compared to analyst estimates of $32.04 million. View LCA-Vision's Earnings History.
Has LCA-Vision been receiving favorable news coverage?
Media headlines about LCAV stock have trended somewhat positive this week, according to Accern Sentiment Analysis. The research group scores the sentiment of news coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. LCA-Vision earned a coverage optimism score of 0.13 on Accern's scale. They also gave news headlines about the healthcare company an impact score of 49.30 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of LCA-Vision?
Shares of LCAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact LCA-Vision?
LCA-Vision's mailing address is 7840 Montgomery Rd, CINCINNATI, OH 45236-4301, United States. The healthcare company can be reached via phone at +1-513-7929292.
MarketBeat Community Rating for LCA-Vision (LCAV)MarketBeat's community ratings are surveys of what our community members think about LCA-Vision and other stocks. Vote "Outperform" if you believe LCAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LCAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
LCA-Vision (NASDAQ:LCAV) Analyst Ratings History
(Data available from 4/24/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
LCA-Vision (NASDAQ:LCAV) Earnings History and Estimates Chart
LCA-Vision (NASDAQ LCAV) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|4/30/2014||Q1 2014||$0.23||($0.01)||$32.04 million||$25.53 million||View||N/A|
|2/18/2014||Q4||($0.08)||($0.08)||$20.55 million||$20.60 million||View||Listen|
|10/29/2013||Q3 2013||($0.10)||($0.08)||$20.78 million||$20.66 million||View||N/A|
|7/30/2013||Q2 2013||($0.11)||$0.02||$23.00 million||$22.60 million||View||Listen|
|4/30/2013||Q1 2013||$0.07||$28.16 million||$28.30 million||View||N/A|
LCA-Vision (NASDAQ:LCAV) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
LCA-Vision (NASDAQ LCAV) Insider Trading and Institutional Ownership History
LCA-Vision (NASDAQ LCAV) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|3/14/2013||Michael J Celebrezze||CEO||Buy||3,450||$2.90||$10,005.00|| |
|2/28/2013||Amy F Kappen||CFO||Buy||1,023||$3.00||$3,069.00|| |
LCA-Vision (NASDAQ LCAV) News Headlines
LCA-Vision (NASDAQ:LCAV) SEC Filings
This page is loading this company's SEC Filings. Please wait...
LCA-Vision (NASDAQ:LCAV) Income Statement, Balance Sheet and Cash Flow Statement
LCA-Vision (NASDAQ LCAV) Stock Chart for Tuesday, April, 24, 2018